Open-label Study with Nalmefene as Needed Use in Alcohol-Dependent Patients with Evidence of Elevated Liver Stiffness and/or Hepatic Steatosis.
Alcohol Alcohol. 2020 Feb 7;55(1):63-70. doi: 10.1093/alcalc/agz078.
Alcohol Alcohol. 2020.
PMID: 31713583
Clinical Trial.